An interventional study of Physical activity and Hypoxic exposure in Physical Activity, Exercise and Hypoxia, sponsored by Universite du Littoral Cote d'Opale. Completed at 2 sites in France. Open to male participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Universite du Littoral Cote d'Opale · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 72 studies in Hypoxia with a site in France — 17 open to participants now, 17 under way, 1 of them phase 3. Hypoxia · France.
Among the 72 studies in Hypoxia with a site in France, this one is the 47th largest by enrollment of the 51 interventional ones that give a count, is one of 6 that started in 2024, is one of 37 with no phase, and was the 72nd registered.
1,081 studies on the registry are indexed under Hypoxia; 213 are open to participants now.
Browse Hypoxia studies →17 of the 72 studies in Hypoxia with a site in France are open now. Recruiting first, the newest first:
Poitiers University Hospital · Sites in France
Ages 18–45 · Healthy volunteers
University Hospital, Grenoble · Sites in France
Ages 18–55 · Healthy volunteers
Universite du Littoral Cote d'Opale · Sites in France
Ages 18–65 · Healthy volunteers
University Hospital, Strasbourg, France · Sites in France
Ages 0 days–1 days
Poitiers University Hospital · Sites in France
Ages 18–75 · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 124 Hypoxia studies recruiting now, 52 (42%) set no upper age limit and 46 (37%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.
This study: 18 Years to 65 Years · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
72 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 3 · Phase 4 5
First in 1963; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 13 is below the median of 45 across 771 interventional studies indexed under Hypoxia.
Median enrollment 40 across the 51 interventional studies, 101 across the 21 observational. Of the 39 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 72 have an industry lead sponsor. The 10 most frequent:
Universite du Littoral Cote d'Opale is the lead sponsor of 11 studies on the registry; 5 are open to participants now.
Universite du Littoral Cote d'Opale has 2 studies filed under Hypoxia — fewer than ten, so there is no comparison to draw.
4 of the studies in Hypoxia with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07516028Universite du Littoral Cote d'OpaleBrain Connectivity and Corticospinal Excitability in Response to Moderate Hypoxia | 2026-12-20 |
| NCT07585227Direction Centrale du Service de Santé des ArméesStudy of the Effects of Acute Exposure to Moderate Altitude Hypoxia on Prospective Memory. | 2026-12-31 |
| NCT05525312University Hospital, MontpellierComparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery. | 2027-03-20 |
| NCT07072975Centre Hospitalier Universitaire, AmiensCPOD Patient's Tolerance of Intermittent Exercise With Inter-exercise Recovery Under Normoxic Hypoxia | 2027-07 |
Add all 4 to your calendar (.ics) → With an account.
Among the 72 studies in Hypoxia with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial was to evaluate the effects of sequentially administrated physical activity and hypoxia on blood glucose, blood pressure and heart rate variability, compared to their isolated counterparts, in healthy individuals. The main question was to answer if this organization could be used as a beneficial modulator of metabolic and cardiovascular homeostasis without additional nervous autonomic strain.
Participants were asked to come for 5 visits at the laboratory for the following experimentations:
Visits number 2, 3, 4, 5 were placed in random order.
1,081 studies on the registry are indexed under Hypoxia; 213 are open to participants now.
This study's enrollment of 13 is below the median of 45 across 771 interventional studies indexed under Hypoxia.
Browse Hypoxia studies →Universite du Littoral Cote d'Opale is the lead sponsor of 11 studies on the registry; 5 are open to participants now.
Compared within Hypoxia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Healthy participants
Other: Physical activity · Other: Hypoxic exposure · Other: Sequentially combined physical activity and hypoxia · Other: Unsupervised control
90 minutes of moderate physical activity alone composed of 45 minutes of continuous moderate aerobic exercice (50-60% of estimated maximal aerobic power) and 45 minutes of moderate resistance exercice (50-60% of estimated maximal strenght).
Also known as: Exercise
Resting in normobaric hypoxia at FiO2 ≈ 14.5%. Hypoxia was provided in a closed environment (tent) with an O2 extractor (Cloud 9, Sporting Edge Ltd, Basingstoke, United Kingdom).
Also known as: Hypoxia
Physical Activity followed by Hypoxia: a reduced-duration condition combining physical activity and hypoxia sequentially, with 20 min of cycling, 20 min of resistance exercise, and 40 min of hypoxic exposure.
Also known as: Exercise, Hypoxia, Combination
A control condition without supervised exercise or hypoxic exposure, during which participants followed their usual daily routine.
Also known as: Control, Unsupervised, Daily living condition
Interstitial glucose concentrations
Interstitial glucose concentration (mg/dl) measured with continuous glucose monitoring (Freestyle Libre Pro iQ, Abbott, Chicago, Illinois, USA). Coefficient of variation, mean absolute glucose and glucose area under the curve normalised by duration of the observed window were used for analyses.
Time frame: During the intervention (90min) and up to 24 hours post-intervention.
Ambulatory blood pressure monitoring
Blood pressure measured with ABPM device every 30 minutes during daytime and every hour during nighttime (ABPM Walk200b, Cardioline S.P.A, Trento, Italy).
Time frame: Immediately post-intervention through the following morning (range: 14 to 22 hours, depending on session time)
Heart rate variability
Heart rate variability measured with a thoracic heart rate strap (Polar H10, Polar Electro Oy, Kempele, Finland). RMSSD, pNN50, SDNN and spectral analyses were performed on R-R intervals.
Time frame: During the 90 min of intervention and the first 6 hours of the following night.
Spontaneous physical activity
Measurement of the physical activity performed spontaneously by the participants by an accelerometer placed on wrist of the non-dominant arm (GT3X, ActiGraph, Pensacola, Florida, USA). Outcome used for control.
Time frame: Up to 48 hours (from 1 day pre-intervention to 1 day post-intervention)
Nutritional intake
Participants used a nutritional diary on the second visit to reproduce the same nutritional intake on the day of each other intervention. Outcome used for standardisation of the study.
Time frame: Each day of the experiment, from the first to the last session (approximately 4 weeks overall)
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Mar 2024 to primary completion in Apr 2026, 25 months.
Of 324 non-industry interventional studies with no phase under Hypoxia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's 25 months is above that.
Counting every sponsor, half of 354 studies reached it within 12 months; a quarter within 3 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universite du Littoral Cote d'Opale